Kinnate Biopharma Inc.
INHIBITORS OF CYCLIN-DEPENDENT KINASES
Last updated:
Abstract:
Provided herein are inhibitors of cyclin-dependent kinases (CDKs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Status:
Application
Type:
Utility
Filling date:
11 Nov 2020
Issue date:
6 May 2021